According to a new market research report "Aseptic Sampling Marketby Type (Manual (Type (Traditional, Single use), Product (Bags, Bottles, Syringes, Accessories)), Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO) - Global Forecast to 2023", published by MarketsandMarkets™, the market is expected to grow at a CAGR of 13.5% from 2018 to 2023, to reach USD 1,247.0 million in 2023 from USD 662.1 million in 2018.
Early buyers will receive 10% customization on this report
Based on application, the upstream processes segment is accounted for the largest share of the market in 2018
On the basis of application, the Aseptic Sampling Market is segmented into upstream process and downstream process. In 2018, the upstream process segment is expected to account for the largest share of the market. Being the start of bioproduction, upstream processes form a key application area for aseptic sampling. Any contamination originating from the upstream process will be carried to the following processes and affect overall production, leading to failure. Their importance in this stage is the key factor supporting the use of aseptic sampling products.
Based on type, the manual aseptic sampling segment is expected to account for the largest share of the market in 2018
On the basis of type, the Aseptic Sampling Market is categorized into manual aseptic sampling and automated aseptic sampling. In 2018, the manual aseptic sampling segment is expected to account for the largest share of the Aseptic Sampling Market. Manual Aseptic sampling is again divided into two segments traditional sampling type and single-use sampling type. In 2018, single-use sampling type is expected to account for the largest share in the manual Aseptic Sampling Market. Single-use aseptic sampling systems help drug manufacturers to mitigate cross-contamination and cost issues, leads to a high share in the market.
The Europe is expected to account for the largest share of the Aseptic Sampling Market in 2018. Government support for new biologics has encouraged the research and development of biologics. North America is accounted for the second-largest share of the market.
The major players operating in the market include Sartorius Stedim Biotech (France), Merck Millipore (Germany), Danaher (US), and Thermo Fisher Scientific (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: email@example.com